Suchergebnisse - "Kato, Sayaka"

PubPharm (103)

1

A Potent Neutralizing Monoclonal Antibody to Human Growth Hormone Suppresses Insulin-Like Growth Factor-1 in Female Rats

enthalten in: Endocrinology | 2024

von Hata, T. | Uematsu, Y. | Sugita, A. | +9

2

Impact of coronavirus disease 2019 on medical practice in endocrine and metabolic diseases in Japan : a nationwide surveillance study conducted by the Japan Endocrine Society

enthalten in: Endocrine journal | 2024

von Manaka, K. | Kato, S. | Sakamoto, R. | +16

3

Imeglimin Exhibits Novel Anti-Inflammatory Effects on High-Glucose-Stimulated Mouse Microglia through ULK1-Mediated Suppression of the TXNIP-NLRP3 Axis

enthalten in: Cells | 2024

von Kato, H. | Iwashita, K. | Iwasa, M. | +5

4

Rapidly progressive interstitial lung disease with positive anti-MDA5 antibody as an immune-related complication of nivolumab : A case report

enthalten in: Respiratory investigation | 2024

von Kato, S. | Sakamoto, K. | Sato, T. | +6

5

Five percent weight loss is a significant 1-year predictor and an optimal 5-year cut-off for reducing the number of obesity-related cardiovascular disease risk components : the Japan Obesity and Metabolic Syndrome Study

enthalten in: Frontiers in endocrinology | 2024

von Yamakage, H. | Jo, T. | Tanaka, M. | +7

6

Discovery of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid derivative as a potent and selective heparanase-1 inhibitor utilizing an improved synthetic approach

enthalten in: Bioorganic & medicinal chemistry letters | 2024

von Imai, Y. | Suzuki, R. | Matsuda, D. | +10

7

Discovery of novel indole derivatives as potent and selective inhibitors of proMMP-9 activation

enthalten in: Bioorganic & medicinal chemistry letters | 2024

von Nishikawa-Shimono, R. | Kuwabara, M. | Fujisaki, S. | +25

8

Novel pathological implications of serum uric acid with cardiovascular disease risk in obesity

enthalten in: Diabetes research and clinical practice | 2023

von Wakabayashi, D. | Kato, S. | Tanaka, M. | +8

9

Structure-based lead optimization to improve potency and selectivity of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid series of heparanase-1 inhibitor

enthalten in: Bioorganic & medicinal chemistry | 2023

von Imai, Y. | Suzuki, R. | Wakasugi, D. | +16

10

Taxifolin Suppresses Inflammatory Responses of High-Glucose-Stimulated Mouse Microglia by Attenuating the TXNIP-NLRP3 Axis

enthalten in: Nutrients | 2023

von Iwasa, M. | Kato, H. | Iwashita, K. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]